Abstrakt
Disclosed are formulations/compositions comprising ibrutinib: (I) as well as processes for preparing such formulations/compositions and methods of treatment of a disease or condition that comprises the use of such formulations/compositions.
Originalsprog | Engelsk |
---|---|
IPC | A61P 35/ 02 A I |
Patentnummer | WO2019238904 |
Land/Område | Danmark |
Prioritetsdato | 15/06/2018 |
Prioritetsnummer | EP20180177987 |
Status | Udgivet - 19. dec. 2019 |
Udgivet eksternt | Ja |